No Prescription |
 |
 | ||
|
SIMLUP Simcard |
|
| ||
No Prescription » Prescription Drugs 15 » SIMLUP Simcard Simvastatin is used together with lifestyle changes (diet weight-loss exercise) to reduce the amount of cholesterol (a fat-like substance) and certain other fatty substances in your blood. Simvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body.Buildup of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and therefore the oxygen supply to your heart brain and other parts of your body. Lowering your blood level of cholesterol and fats may help to decrease your chances of getting heart disease angina (chest pain) strokes and heart attacks. In addition to taking a cholesterol-lowering medication making certain changes in your daily habits can also lower your cholesterol blood levels. You should eat a diet that is low in saturated fat and cholesterol (see SPECIAL DIETARY) exercise 30 minutes on most if not all days and lose weight if you are overweight. Buy SIMLUP Simcard and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About SIMLUP Simcard: Product Type: Prescription Drugs 15 SIMLUP ( Simcard Zocor Generic Simvastatin ) SIMLUP (Simcard Zocor Generic Simvastatin) Simcard Zocor Generic Simvastatin 10mg Tabs Simcard Zocor Generic Simvastatin SIMLUP
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
